Senescent muscle precursor cells depend on ROS-driven Akt/mTORC1 signaling to maintain their dysfunctional state. Antioxidant treatment can suppress this pathway, reduce inflammatory output, and selectively eliminate senescent cells while sparing healthy muscle precursors—a mechanism relevant to cellular senescence reversal strategies in aging muscle.
Key Points
- Senescent myoblasts rely on ROS-dependent PI3K/Akt/mTORC1 dysregulation
- Antioxidants suppress pro-inflammatory cytokines and enhance differentiation capacity
- Prolonged antioxidant exposure selectively kills senescent but not healthy cells
Longevity Analysis
Senescent cells accumulate with age and impair tissue regeneration while driving systemic inflammation through their secretory profile. This research identifies a redox vulnerability specific to senescent muscle precursor cells, creating a therapeutic window where antioxidant modulation can both suppress their inflammatory signaling and trigger their selective removal. The finding suggests that antioxidant compounds may work as senotherapeutics not through blanket free radical scavenging, but through targeted disruption of the metabolic dysregulation that sustains senescence—a distinction that reframes how plant-based interventions might address age-related muscle decline and the accumulation of non-functional cells that interfere with regenerative capacity.
Original published by Wiley Aging Cell, by Vladimir Belhac, Alex Dillingham, Emilia Coward, Bradley Teal, Mark C. Turner, Stephanie D. Gagnon, Jiani Qian, Harry Wilford, Ella Warren, Natalie Moger, Bernadette Carroll, Owen G. Davies, Hannah F. Dugdale, Neil R. W. Martin .